Five-Year Cost of Dementia: Medicare by White, Lindsay et al.
University of Pennsylvania
ScholarlyCommons
Research Briefs Leonard Davis Institute of Health Economics
4-29-2019
Five-Year Cost of Dementia: Medicare
Lindsay White
University of Pennsylvania
Paul Fishman
Anirban Basu
Paul K. Crane
Eric B. Larson
See next page for additional authors
Follow this and additional works at: https://repository.upenn.edu/ldi_researchbriefs
This paper is posted at ScholarlyCommons. https://repository.upenn.edu/ldi_researchbriefs/53
For more information, please contact repository@pobox.upenn.edu.
White, Lindsay; Fishman, Paul; Basu, Anirban; Crane, Paul K.; Larson, Eric B.; and Coe, Norma B.. Five-Year Cost of Dementia:
Medicare. LDI Research Briefs. 2019; No. 53. https://ldi.upenn.edu/brief/five-year-cost-dementia-medicare
" >
https://ldi.upenn.edu/brief/five-year-cost-dementia-medicare
Five-Year Cost of Dementia: Medicare
Abstract
About 5.5 million older adults are living with dementia, a chronic, progressive disease characterized by severe
cognitive decline. This number will likely grow significantly as the U.S. population ages, which has cost
implications for the Medicare program. A full accounting of these additional expenses will help policymakers
plan for them in their Medicare budgets. In this study, Norma Coe and colleagues examined survival and
Medicare expenditures in older adults with and without dementia to estimate dementia’s incremental costs to
Medicare in the five years after diagnosis.
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About 5.5 million older adults are living with dementia, a chronic, 
progressive disease characterized by severe cognitive decline. 
This number will likely grow significantly as the U.S. population 
ages, which has cost implications for the Medicare program. A full 
accounting of these additional expenses will help policymakers 
plan for them in their Medicare budgets.
This study examined survival and Medicare expenditures in 
older adults with and without dementia to estimate dementia’s 
incremental costs to Medicare in the five years after diagnosis. 
Patients with dementia had significantly higher expenditures in 
the 12 months prior to diagnosis than patients without dementia 
($17,116 vs. $10,085).
IMPLICATIONS
  Dementia’s incremental costs to Medicare are significant: the 480,000 patients newly diagnosed with Alzheimer’s in 2017 will add $3.2 billion to 
Medicare spending in the next five years.
  Given lower costs in the last month of life, policies to reduce end-of-life costs for dementia patients may not be effective in reducing overall 
Medicare expenditures.
  Forty percent of the sample was diagnosed in an inpatient setting, leading to high costs around the time of diagnosis. Future work should examine 
what role early detection could play in reducing these costs.
  Subsequent research should explore sociodemographic differences in dementia costs and how to reduce preventable Part A service use.
ESTIMATED 5-YEAR MEDICARE EXPENDITURES (Parts A and B)
Study: 
  Sample of 4,010 older adults with dementia from longitudinal 
Health & Retirement Survey
  Looked at Medicare part A and B expenditures from 1991-
2012, 12 months before and up to 60 months after diagnosis 
  Estimated 5-year costs for those with a dementia diagnosis 
and for the same participants in the absence of dementia  
  Accounted for changes in survival and service use 
attributable to dementia
PATIENTS WITH
DEMENTIA
$71,917
IN THE FIVE YEARS AFTER DIAGNOSIS, INCREMENTAL 
COSTS FOR PATIENTS WITH DEMENTIA WERE…
SAME PATIENTS WITHOUT 
DEMENTIA 
$56,214
INCREMENTAL  
COST PER PATIENT
$15,704 — —
CONCENTRATED IN  
YEAR 1 AFTER DIAGNOSIS
  Half of costs occurred in year 1 
and decreased each year until the 
difference in the presence and 
absence of a dementia diagnosis 
was nearly zero by year 5.
  Average costs were lower in the 
last month of life for dementia 
patients, due to low service use.
DRIVEN PRIMARILY BY GREATER 
INTENSITY OF SERVICE USE
  Greater use of Part A services 
(including inpatient, skilled 
nursing, and hospice care) 
accounted for most of the cost.
  Use of Part B services (outpatient 
care) was higher for dementia 
patients in year 1, but did not differ 
significantly over five years.
AFFECTED BY DIFFERENCES 
IN SEX-SPECIFIC SURVIVAL
  For women, survival time was 
unchanged by a dementia diagnosis. 
Costs were higher because of 
increased use of services. 
  For men, a dementia diagnosis 
reduced survival. Greater use of 
services was offset substantially 
by decreased survival time. 
